Feedback / Questions
MesoPher (autologous dendritic cell vaccine) - Erasmus MC, Amphera
https://www.businesswire.com/news/home/20220504005575/en/Amphera%E2%80%99s-MesoPher-Cell-Therapy-Demonstrates-Favourable-Safety-and-Promising-Survival-in-a-Phase-II-Clinical-Trial-in-Resected-Pancreatic-Cancer
May 4, 2022
SHARE THIS
Print
Email
More sharing
Reddit
StumbleUpon
Delicious
Prev
Next